Status:
COMPLETED
Statins Evaluation in Coronary Procedures and Revascularization Trial
Lead Sponsor:
Hospital do Coracao
Collaborating Sponsors:
Ministry of Health, Brazil
Conditions:
Acute Coronary Syndrome
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether a loading dose of atorvastatin before percutaneous intervention procedures in acute coronary syndromes is effective to reduce major cardiovascular eve...
Detailed Description
Background: Strategies to reduce complications in acute coronary syndrome treatment have been largely studied. Due to its pleiotropic effects statins are considered an important tool on atheroscleroti...
Eligibility Criteria
Inclusion
- Acute coronary syndrome patients intending to undergo percutaneous coronary intervention.
Exclusion
- Younger than 18 years
- Presence of any contraindication to statin (Pregnant women, breast-feeding women or statin hypersensibility)
- Advanced hepatic disease
- Use of statins at the maximum dosage in the last 24 hours before the loading dose of the study drug
- Use of fibrate in the last 24 hours
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2018
Estimated Enrollment :
4191 Patients enrolled
Trial Details
Trial ID
NCT01448642
Start Date
April 1 2012
End Date
April 1 2018
Last Update
June 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital do Coracao
São Paulo, São Paulo, Brazil, 04005-000